| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Keybanc analyst Scott Schoenhaus upgrades Progyny (NASDAQ:PGNY) from Sector Weight to Overweight and announces $30 price tar...
JP Morgan analyst Lisa Gill maintains Progyny (NASDAQ:PGNY) with a Neutral and raises the price target from $25 to $26.
Full Year 2025 Outlook:Revenue is now projected to be $1.263 billion to $1.278 billion, reflecting growth of 8.2% to 9.5%; excl...
Fourth Quarter of 2025 Outlook:Revenue is projected to be $292.7 million to $307.7 million, reflecting a change of (1.9)% to 3....